-
Rex Medical v. Intuitive Surgical: The Federal Circuit Draws a Hard Line on Apportionment
The Federal Circuit’s decision in Rex Medical, L.P. v. Intuitive Surgical, Inc. presents a familiar but still sobering outcome: a jury finds infringement and validity, awards substantial damages,…
4 min read
-
Focus Prods v. Kartri Sales: When Restriction Practice Becomes Prosecution History Disclaimer
The Federal Circuit’s decision in Focus Products Group International, LLC v. Kartri Sales Co., Inc. delivers a wide-ranging opinion that touches nearly every corner of intellectual property litigation:…
4 min read
-
Apex Bank v. CC Serve Corp.: When “Highly Similar” Means Consistently Similar Across the DuPont Factors
The Federal Circuit’s September 25, 2025 decision in Apex Bank v. CC Serve Corp. offers an important reminder that the DuPont likelihood-of-confusion factors are not a cafeteria menu.…
4 min read
-
Bayer Pharma v. Mylan Pharmaceuticals: When “Clinically Proven Effective” Cannot Rescue an Anticipated Treatment Method
The Federal Circuit’s September 23, 2025 decision in Bayer Pharma Aktiengesellschaft v. Mylan Pharmaceuticals Inc., No. 23-2434, delivers a sharp reminder that post-hoc validation, even in the form…
4 min read
-
Finesse Wireless LLC v. AT&T Mobility LLC: When Expert Testimony Cannot Carry the Infringement Verdict
On September 24, 2025, the Federal Circuit issued a sweeping reversal of a significant Eastern District of Texas jury verdict in Finesse Wireless LLC v. AT&T Mobility LLC,…
4 min read
-
Future Link Systems, LLC v. Realtek Semiconductor Corp.: When Sanctions Convert a Dismissal Into Prevailing Party Status
The Federal Circuit’s decision in Future Link Systems, LLC v. Realtek Semiconductor Corp., Nos. 2023-1056, 2023-1057 (Fed. Cir. Sept. 9, 2025), addresses a recurring but unsettled issue in…
4 min read
